FDA is petitioned to boost enforcement of trial sponsors that fail to register studies or report results

Previous
Previous

FDA Accused of Laxity Over Posting of Clinical Trial Results

Next
Next

UAEM North America Pressures U.S. FDA for Clinical Trial Transparency